241 related articles for article (PubMed ID: 19914542)
1. Biomarkers for angiogenesis and antiangiogenic drugs in clinical oncology.
Bertolini F
Breast; 2009 Oct; 18 Suppl 3():S48-50. PubMed ID: 19914542
[TBL] [Abstract][Full Text] [Related]
2. Molecular and cellular biomarkers for angiogenesis in clinical oncology.
Bertolini F; Mancuso P; Shaked Y; Kerbel RS
Drug Discov Today; 2007 Oct; 12(19-20):806-12. PubMed ID: 17933680
[TBL] [Abstract][Full Text] [Related]
3. Circulating endothelial cells as biomarkers in clinical oncology.
Mancuso P; Bertolini F
Microvasc Res; 2010 May; 79(3):224-8. PubMed ID: 20176038
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy and the tumor microenvironment: the contribution of circulating endothelial cells.
Bertolini F
Cancer Metastasis Rev; 2008 Mar; 27(1):95-101. PubMed ID: 18066648
[TBL] [Abstract][Full Text] [Related]
5. Progress and challenges in the identification of biomarkers for EGFR and VEGFR targeting anticancer agents.
Le Tourneau C; Vidal L; Siu LL
Drug Resist Updat; 2008 Jun; 11(3):99-109. PubMed ID: 18515176
[TBL] [Abstract][Full Text] [Related]
6. The multifaceted circulating endothelial cell in cancer: towards marker and target identification.
Bertolini F; Shaked Y; Mancuso P; Kerbel RS
Nat Rev Cancer; 2006 Nov; 6(11):835-45. PubMed ID: 17036040
[TBL] [Abstract][Full Text] [Related]
7. Targeting angiogenesis in head and neck cancer.
Seiwert TY; Cohen EE
Semin Oncol; 2008 Jun; 35(3):274-85. PubMed ID: 18544442
[TBL] [Abstract][Full Text] [Related]
8. Anti-VEGF and beyond: shaping a new generation of anti-angiogenic therapies for cancer.
Bertolini F; Marighetti P; Martin-Padura I; Mancuso P; Hu-Lowe DD; Shaked Y; D'Onofrio A
Drug Discov Today; 2011 Dec; 16(23-24):1052-60. PubMed ID: 21875682
[TBL] [Abstract][Full Text] [Related]
9. Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas.
Smirnov DA; Foulk BW; Doyle GV; Connelly MC; Terstappen LW; O'Hara SM
Cancer Res; 2006 Mar; 66(6):2918-22. PubMed ID: 16540638
[TBL] [Abstract][Full Text] [Related]
10. Circulating endothelial cells as biomarkers of prostate cancer.
Georgiou HD; Namdarian B; Corcoran NM; Costello AJ; Hovens CM
Nat Clin Pract Urol; 2008 Aug; 5(8):445-54. PubMed ID: 18682720
[TBL] [Abstract][Full Text] [Related]
11. A surrogate marker to monitor angiogenesis at last.
Schneider M; Tjwa M; Carmeliet P
Cancer Cell; 2005 Jan; 7(1):3-4. PubMed ID: 15652744
[TBL] [Abstract][Full Text] [Related]
12. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
Shojaei F; Ferrara N
Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
[TBL] [Abstract][Full Text] [Related]
13. New anti-angiogenic strategies in pediatric solid malignancies: agents and biomarkers of a near future.
Taylor M; Rössler J; Geoerger B; Vassal G; Farace F
Expert Opin Investig Drugs; 2010 Jul; 19(7):859-74. PubMed ID: 20470190
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of circulating endothelial cell detection in oncology.
Kraan J; Sleijfer S; Foekens JA; Gratama JW
Drug Discov Today; 2012 Jul; 17(13-14):710-7. PubMed ID: 22306349
[TBL] [Abstract][Full Text] [Related]
15. [Angiogenesis and antiangiogenic cancer therapy].
Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
[TBL] [Abstract][Full Text] [Related]
16. [Circulating endothelial cells: biomarkers for monitoring activity of antiangiogenic therapy].
Farace F; Bidart JM
Bull Cancer; 2007 Jul; 94 Spec No():S254-9. PubMed ID: 17846012
[TBL] [Abstract][Full Text] [Related]
17. Assessing tumor angiogenesis: increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells.
Rabascio C; Muratori E; Mancuso P; Calleri A; Raia V; Foutz T; Cinieri S; Veronesi G; Pruneri G; Lampertico P; Iavarone M; Martinelli G; Goldhirsch A; Bertolini F
Cancer Res; 2004 Jun; 64(12):4373-7. PubMed ID: 15205354
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis and gliomas: current issues and development of surrogate markers.
Jouanneau E
Neurosurgery; 2008 Jan; 62(1):31-50; discussion 50-2. PubMed ID: 18300890
[TBL] [Abstract][Full Text] [Related]
19. Microvascular endothelial cell heterogeneity: general concepts and pharmacological consequences for anti-angiogenic therapy of cancer.
Langenkamp E; Molema G
Cell Tissue Res; 2009 Jan; 335(1):205-22. PubMed ID: 18677515
[TBL] [Abstract][Full Text] [Related]
20. [Neoplasms and angiogenesis].
Lewy-Trenda I
Pol Merkur Lekarski; 2002 Sep; 13(75):225-8. PubMed ID: 12474576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
